Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 30;16(1):1444.
doi: 10.1007/s12672-025-03284-7.

Bibliometric insights into molecular and bioinformatic research trends on ameloblastoma

Yoithapprabhunath Thuckanaickenpalayam Ragunathan  1 , Ramdas Madhavan Nirmal  2 , Supriya Kheur  3 , Kumar Chandan Srivastava  4   5 , Swetha Pasupuleti  6 , Srichinthu Kenniyan Kumar  7 , Armen A Muradyan  8 , Artak Heboyan  9   10
Affiliations

Bibliometric insights into molecular and bioinformatic research trends on ameloblastoma

Yoithapprabhunath Thuckanaickenpalayam Ragunathan et al. Discov Oncol. .

Abstract

Objectives: The study aimed to evaluate the significant trends of advancement in the body of literature of specialty journals on molecular biological investigations of ameloblastoma (AB). Additionally, this bibliometric study sought to identify the authors, organizations, journals, and countries from emerging regions that have exerted the most significant influence on molecular biological and bioinformatics studies on AB.

Novelty of study: The novelty of this study lies in its comprehensive bibliometric integration of bioinformatics and molecular perspectives, offering a structured roadmap for future ameloblastoma research.

Materials and methods: A complete list of AB molecular biological research citations was found in Scopus. The search was restricted to papers published between 2014 and 2024, but there were no restrictions on the language or type of research studies. The study examined total citations, citation density, journal name, impact factor, journal category, quartile, published year, authors, affiliations, and study type.

Results: The analysis included collecting 112 publications published between 2014 and 2024. There were 95 original research papers, 6 systematic reviews, 5 case reports, 3 brief communications, and 6 systematic reviews and meta-analyses. Our analysis identifies noteworthy authors and nations that have contributed, with Brazil emerging as a leading figure in this field of study.

Conclusions: The research on AB, especially its biological profile, has changed significantly across the years, as can be observed by perusing the contents of the papers included here. The data from this study would help the researchers target specific objectives for future research in more relevant avenues.

Keywords: Ameloblastoma; BRAF V600E protein; Bibliometric analysis; Citation density; Immunohistochemistry.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval Consent to participate: Not Applicable, as the current study is a bibliometric analysis based which is entirely based on previously published literature from publicly accessible databases. It does not involve human participants, animals, or identifiable personal data. Hence, the study is exempted from the ethical approval. Not Applicable, as there is no involvement of human participants, personal data, or clinical samples in this bibliometric analysis. Consent for publication: Not Applicable, as the study is based entirely on analysis of published literature from publicly available databases (e.g., Scopus, Web of Science, PubMed), and does not include any identifiable personal data or unpublished material. All authors have reviewed and approved the final manuscript and gave consent to its publication in Discover Oncology. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Total number of year-wise publications in the selected journals over a past decade
Fig. 2
Fig. 2
Total number of publications and citations based on the selected journals
Fig. 3
Fig. 3
Journals’ Impact Factor vs. Number of Publications graph, comparing journal impact factors with publication counts
Fig. 4
Fig. 4
Institutional Contributions Graph showing the number of publications by universities
Fig. 5
Fig. 5
Trend of Citation Density Over Time showing how citation density has changed over the years
Fig. 6
Fig. 6
Geographical Distribution of Publications, showing country-wise research contributions
Fig. 7
Fig. 7
Country of origin and the number of publications included during the study period
Fig. 8
Fig. 8
Keywords cited at least two or more times in the selected molecular biological studies on ameloblastoma
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Fuchigami T, Ono Y, Kishida S, Nakamura N. Molecular biological findings of ameloblastoma. Japanese Dent Sci Rev. 2021;57:27–32. 10.1016/j.jdsr.2020.12.003. - PMC - PubMed
    1. Fregnani ER, da Cruz Perez DE, de Almeida OP, Kowalski LP, Soares FA, de Abreu Alves F. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. Int J Oral Maxillofac Surg. 2010;39(2):145–9. 10.1016/j.ijom.2009.11.022. - PubMed
    1. Marín-Márquez C, Adisa AO, Niklander SE, Kirby J, Hunter KD. Genomic and transcriptomic analysis of ameloblastoma reveals distinct molecularly aggressive phenotypes. Mod Pathol. 2025;38(3):100682. 10.1016/j.modpat.2024.100682. - PubMed
    1. Liu XH, Zhong NN, Yi JR, Lin H, Liu B, Man QW. Trends in research of odontogenic keratocyst and ameloblastoma. J Dent Res. 2025;104(4):347–68. 10.1177/00220345241282256. - PubMed
    1. Gunardi I, Sufiawati I, Goenawan H, Herawati DMD, Lesmana R, Abdullah AG. Research trends in molecular biological studies on oral squamous cell carcinoma: A bibliometric analysis. Oncol Rev. 2023;17:11585. 10.3389/or.2023.11585. - PMC - PubMed

LinkOut - more resources